These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6776037)

  • 1. Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils.
    Sánchez-Crespo M; Alonso F; Egido J
    Immunology; 1980 Aug; 40(4):645-55. PubMed ID: 6776037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.
    Camussi G; Aglietta M; Coda R; Bussolino F; Piacibello W; Tetta C
    Immunology; 1981 Feb; 42(2):191-9. PubMed ID: 6161885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF.
    Betz SJ; Lotner GZ; Henson PM
    J Immunol; 1980 Dec; 125(6):2749-55. PubMed ID: 6159420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes.
    Mencia-Huerta JM; Benveniste J
    Eur J Immunol; 1979 May; 9(5):409-15. PubMed ID: 385330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes.
    Elstad MR; Prescott SM; McIntyre TM; Zimmerman GA
    J Immunol; 1988 Mar; 140(5):1618-24. PubMed ID: 3126231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological mechanisms of human platelet involvement.
    Camussi G; Tetta C; Segoloni G; Vercellone A
    Ric Clin Lab; 1978; 8(4):262-72. PubMed ID: 734319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187.
    Conroy MC; Orange RP; Lichtenstein LM
    J Immunol; 1976 Jun; 116(6):1677-81. PubMed ID: 58045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C regulates the synthesis of platelet-activating factor by human monocytes.
    Elstad MR; McIntyre TM; Prescott SM; Zimmerman GA
    Am J Respir Cell Mol Biol; 1991 Feb; 4(2):148-55. PubMed ID: 1846746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an immunostimulatory substance of Klebsiella pneumoniae on inflammatory responses of human granulocytes, basophils and platelets.
    Scheffer J; Ounis I; König W
    Arzneimittelforschung; 1991 Aug; 41(8):815-20. PubMed ID: 1723598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passage of immune complexes through vascular walls. Evidence for the role of an immediate hypersensitivity mechanism and its mediator: platelet-activating factor.
    Benveniste J
    Rheumatology; 1975; 6():293-302. PubMed ID: 53875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.
    Henson PM; Pinckard RN
    Monogr Allergy; 1977; 12():13-26. PubMed ID: 335211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intracellular retention of newly synthesized platelet-activating factor.
    Lynch JM; Henson PM
    J Immunol; 1986 Oct; 137(8):2653-61. PubMed ID: 3093579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcellular distribution of platelet-activating factor in stimulated human neutrophils.
    Riches DW; Young SK; Seccombe JF; Henson JE; Clay KL; Henson PM
    J Immunol; 1990 Nov; 145(9):3062-70. PubMed ID: 2212673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils.
    O'Donnell MC; Henson PM; Fiedel BA
    Immunology; 1978 Dec; 35(6):953-8. PubMed ID: 738767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators.
    Williams JD; Czop JK; Austen KF
    J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and partial characterization of (PAF) platelet-activating-factor].
    Benveniste J; Camussi J; Mencia-Huerta JM; Polonsky J
    Ann Immunol (Paris); 1977; 128(1-2):259-60. PubMed ID: 848883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.
    Arnoux B; Duval D; Benveniste J
    Eur J Clin Invest; 1980 Dec; 10(6):437-41. PubMed ID: 6788561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic comparison between basophils and other leukocytes from human blood.
    de Boer M; Roos D
    J Immunol; 1986 May; 136(9):3447-54. PubMed ID: 3007619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
    Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
    J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.